ReviewEmerging infectious diseases2026
Emerging Risk for Human T-Cell Leukemia Virus Type 1 Transmission with HIV-Positive Breastfeeding Support.
Review in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human T-cell leukemia virus 1 (HTLV-1) is a neglected retrovirus affecting 5-10 million persons worldwide. Most infections are asymptomatic, but HTLV-1 can cause adult T-cell leukemia or lymphoma and HTLV-1-associated myelopathy. Although mother-to-child transmission through breastfeeding is preventable, few countries have policies that include antenatal screening. The World Health Organization recommends integrating HTLV-1 into HIV and sexually transmitted infection strategies. HIV guidelines in high-income countries increasingly support breastfeeding under controlled conditions, creating increased risk for unrecognized HTLV-1 transmission. We reviewed existing policies for HTLV-1 mother-to-child transmission and considered integration of HTLV prevention into HIV response. We discovered inconsistent guidance across HIV, pediatric, and obstetric fields, leading to conflicting counseling of expectant mothers. Integration of HTLV-1 prevention into HIV guidelines and harmonization with maternal and child health policies is essential for awareness among providers. Prevention through screening and avoiding breastfeeding remains the cornerstone of HTLV-1 control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.